analgesic/headache

FIELD OF THE INVENTION This invention relates to magnesium-based compositions for treating migraine headaches, and methods for using the same. BACKGROUND OF THE INVENTION Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the gastric

FIELD OF THE INVENTION This invention relates to magnesium-based analgesic compositions for treating migraine headaches, and methods for using the same. BACKGROUND OF THE INVENTION Analgesic compositions comprising magnesium salts have been used to treat a variety of ailments as well as reduce the

BACKGROUND OF THE INVENTION The present invention is novel compounds, which are of 4'-hydroxyphenylacetic acid having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia, inflammatory eye disorders,

FIELD OF THE INVENTION The present invention relates to devices and methods for treatment of ailments particularly headaches. BACKGROUND OF THE INVENTION Many people suffer from ailments such as headaches, migraine headaches, chronic eye strain and sinus maladies. Common symptoms of these ailments

This application is a 371 of PCT/JP94/00120. TECHNICAL FIELD The present invention relates to a medical use of threo-3-(3,4-dihydroxyphenyl)serine (hereinafter abbreviated as threo-DOPS). More particularly, the present invention relates to a medical use of threo-DOPS as an analgesic drug, especially

BACKGROUND OF THE INVENTION Morphine or other bimodally-acting opioid agonists are administered to relieve severe pain due to the fact that they have analgesic effects mediated by their activation of inhibitory opioid receptors on nociceptive neurons (see North, Trends Neurosci., Vol. 9, pp. 114-117

BACKGROUND OF THE INVENTION An analgesic is a drug that relieves pain (analgesia). These "pain killers" are not anesthetics. Anesthetics reversibly eliminate sensation, while analgesics raise the level of sensitivity to pain. Analgesic medications may be administered intravenously, orally, or

BACKGROUND OF THE INVENTION The present invention relates to a method of alleviating or preventing a migraine headache through the administration of a mast cell degranulation blocking agent. A) Migraines Migraine headaches are known to produce the most intense headache reported, which are comparable

BACKGROUND OF THE INVENTION This invention relates to novel compositions of matter containing optically pure R-etodolac. These compositions possess potent activity in treating pain including, but not limited to, pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for

BACKGROUND OF THE INVENTION This invention relates to novel compositions of matter containing optically pure R-ketorolac. These compositions possess potent activity in treating pain, including but not limited to pain associated with toothaches, headaches, sprains, joint pain and surgical pain, for

BACKGROUND OF THE INVENTION This invention relates to novel compositions of matter containing optically pure R(-) ketoprofen. These compositions possess potent activity in treating pain including but not limited to, pain associated with toothaches, headaches, sprains, joint pain and surgical pain,

BACKGROUND OF THE PRESENT INVENTION The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,

BACKGROUND OF THE PRESENT INVENTION The present invention is novel compounds, which are derivatives of hydroxybenzylamine and as such are related to capsaicin. The present compounds have antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel

BACKGROUND OF THE PRESENT INVENTION The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,

BACKGROUND OF THE PRESENT INVENTION The present invention is novel compounds, which are derivatives of benzoic acid and benzoic acid esters--having antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia,